Effect of acarbose on cardiovascular events and new-onset diabetes in patients with coronary heart disease and impaired glucose tolerance

Future Cardiology
Yidong Wei, Wen Xu

Abstract

Many studies indicated postprandial hyperglycemia was closely related to the development of diabetes and the risk of cardiovascular disease. Acarbose was shown to delay the onset of diabetes in people with impaired glucose tolerance that was at low cardiovascular risk. The Acarbose Cardiovascular Evaluation (ACE) trial formally evaluated whether acarbose could reduce the frequency of cardiovascular events in patients with established coronary heart disease and impaired glucose tolerance, and whether the incidence of Type 2 diabetes could be reduced. The Acarbose Cardiovascular Evaluation trial represented that acarbose did not reduce the risk of Major Adverse Cardiovascular Events (MACE), but the risk of new-onset diabetes by 18% for a median of 5.0 years follow-up.

References

Jun 28, 2002·Lancet·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trail Research Group
Jul 24, 2003·JAMA : the Journal of the American Medical Association·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trial Research Group
Apr 10, 2004·Stroke; a Journal of Cerebral Circulation·Markolf HanefeldTheodora Temelkova-Kurktschiev
Jun 16, 2004·Circulation·Katherine EspositoUNKNOWN Campanian Postprandial Hyperglycemia Study Group
Oct 16, 2004·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·G RudofskyA Bierhaus
Aug 28, 2007·The American Journal of Cardiology·James H O'Keefe, David S H Bell
Mar 11, 2008·Expert Review of Cardiovascular Therapy·Harold E BaysRobert R Henry
Mar 17, 2010·The New England Journal of Medicine·Rury R HolmanRobert M Califf
Nov 10, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·T AndoK Ono
Apr 30, 2011·Circulation Research·Joseph W GordonLorrie A Kirshenbaum
Feb 11, 2012·Journal of the American College of Cardiology·Scott M Grundy
Nov 14, 2012·Nutrition Research·Eunice Mah, Richard S Bruno
Feb 12, 2013·Atherosclerosis·Stijn C H van den OordArend F L Schinkel
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
May 8, 2014·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Lars RydénJose Luis Zamorano
Jun 24, 2014·American Heart Journal·Rury R HolmanUNKNOWN ACE Study Group
Jul 22, 2014·Diabetes/metabolism Research and Reviews·Jianping WengSanjay Kalra
Sep 15, 2014·The Lancet. Diabetes & Endocrinology·Juliana C N ChanGuang Ning
Jun 19, 2015·Cardiovascular Diabetology·Hiroki OeUNKNOWN FESC, for Effect of a DPP-4 inhibitor on left ventricular diastolic dysfunction in patients with type 2 diabetes and diabeti
Sep 9, 2015·JAMA : the Journal of the American Medical Association·David M Nathan
Feb 20, 2016·Circulation Research·Michael A Gimbrone, Guillermo García-Cardeña
May 28, 2016·Circulation Research·Eberhard StandlDarren K McGuire
Jul 8, 2017·Cardiovascular Diabetology·Michio ShimabukuroUNKNOWN Collaborators on the Effect of Miglitol on Glucose Metabolism in Acute Coronary Syndrome (MACS) Study
Aug 6, 2017·Cardiovascular Drugs and Therapy·Masanori AsakuraUNKNOWN ABC investigators

❮ Previous
Next ❯

Citations

Dec 23, 2020·International Journal of Biological Macromolecules·Zhao-Rong LiMouming Zhao
Jul 12, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A M SwarazMd Obayed Raihan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Related Papers

European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
Uwe ZeymerSTOP-NIDDM Trial Research Group
© 2022 Meta ULC. All rights reserved